A clinician completes an HIV diagnostic test at Mangochi District Hospital in Malawi. / Credit: Thoko Chikondi for USAID

HIV/ AIDS Product Development Research

USAID's HIV/AIDS research program lays the scientific foundation for interventions that can achieve epidemic control through two dedicated sectors: Microbicides and Vaccines.

Read More About What We Do

What We Do

USAID’s HIV/AIDS Research program provides leadership by:

  • Developing the HIV/AIDS research agenda and cultivating strategic partnerships to implement HIV/AIDS research and technology development programs.

  • Disseminating research findings and supporting programmatic and policy applications, including responding to research inquiries.

  • Supporting sustainable capacity building and using local capacity for HIV/AIDS research.

The USAID HIV/AIDS research program lays the scientific foundation for HIV/AIDS interventions that can achieve epidemic control through two dedicated sectors, Microbicides and Vaccines.

 USAID's Work With HIV/AIDS Product Development Research Includes: 

The Mosiac Project's NextGen Squad after the Gender and Youth Leadership Opening Workshop in April 2022. Credit: USAID MOSIAC/FHI360

MICROBICIDES

 

USAID supports the research and development of HIV prevention products for women that in addition to being safe and effective, will be acceptable, affordable, scalable, and deliverable in settings where they are needed most.

 

USAID invests in the design and testing of improved vaccine candidates, guided by African scientific leadership, to move the world closer to a globally-effective HIV vaccine. Photo Credit: International AIDS Vaccine Initiative

VACCINES

 

USAID recognizes that a vaccine is the ultimate tool to control the HIV epidemic and has supported research and development for a safe and globally effective HIV vaccine for more than two decades.